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Abstract
Background: Andes virus (ANDV), a rodent-borne Hantavirus, is the major etiological agent of Hantavirus
cardiopulmonary syndrome (HCPS) in South America, which is mainly characterized by a vascular leakage with high
rate of fatal outcomes for infected patients. Currently, neither specific therapy nor vaccines are available against
this pathogen. ANDV infects both dendritic and epithelial cells, but in despite that the severity of the disease
directly correlates with the viral RNA load, considerable evidence suggests that immune mechanisms rather than
direct viral cytopathology are responsible for plasma leakage in HCPS. Here, we assessed the possible effect of
soluble factors, induced in viral-activated DCs, on endothelial permeability. Activated immune cells, including DC,
secrete gelatinolytic matrix metalloproteases (gMMP-2 and -9) that modulate the vascular permeability for their
trafficking.
Methods: A clinical ANDES isolate was used to infect DC derived from primary PBMC. Maturation and pro-
inflammatory phenotypes of ANDES-infected DC were assessed by studying the expression of receptors, cytokines
and active gMMP-9, as well as some of their functional status. The ANDES-infected DC supernatants were assessed
for their capacity to enhance a monolayer endothelial permeability using primary human vascular endothelial cells
(HUVEC).
Results: Here, we show that in vitro primary DCs infected by a clinical isolate of ANDV shed virus RNA and
proteins, suggesting a competent viral replication in these cells. Moreover, this infection induces an enhanced
expression of soluble pro-inflammatory factors, including TNF-a and the active gMMP-9, as well as a decreased
expression of anti-inflammatory cytokines, such as IL-10 and TGF-b. These viral activated cells are less sensitive to
apoptosis. Moreover, supernatants from ANDV-infected DCs were able to indirectly enhance the permeability of a
monolayer of primary HUVEC.
Conclusions: Primary human DCs, that are primarily targeted by hantaviruses can productively be infected by
ANDV and subsequently induce direct effects favoring a proinflammatory phenotype of infected DCs. Finally, based
on our observations, we hypothesize that soluble factors secreted in ANDV-infected DC supernatants, importantly
contribute to the endothelial permeability enhancement that characterize the HCPS.
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Hantaviruses are rodent-born enveloped RNA-viruses
belonging to Bunyaviridae family. Two major severe
pathologies associated to Hantaviruses have been
reported: hemorrhagic fever with renal syndrome (HFRS)
in the Eurasia and Hantavirus cardiopulmonary syn-
drome (HCPS) in the Americas. HCPS is more frequently
associated (40%) to fatal outcomes than HFRS (<1%) [1].
Andes Hantavirus (ANDV) is the major etiological agent
of the HCPS in South America, syndrome characterized
by the presence of high amounts of pulmonary fluids
leading to an edema evolving to a cardiogenic shock that
synergistically acts with hypovolemia due to capillary
leakage resulting in an abrupt cardiopulmonary collapse
[2]. Although disease severity directly correlates with the
viral RNA load [3], considerable evidence exists suggest-
ing that immune mechanisms rather than direct viral
cytopathology are indeed responsible for the massive vas-
cular dysfunction and plasma leakage of HFRS and HCPS
[4,5].
The hemorrhagic viruses, including the members of the
Bunyaviridae as well as dengue viruses, target endothelial
cells and immune cells, mainly monocyte-derived cells
such as the professional antigen-presenting cells, Dendritic
cells (DCs) [6-8]. DCs activation triggers their maturation
and trans-endothelial migration occurring during wound
healing or inflammation. These processes require extracel-
lular matrix remodeling and involve changes in endothelial
permeability regulated by the production of matrix metal-
loproteases (gMMPs) or vascular endothelial growth factor
(VEGF). However, in excess, these soluble factors can have
deleterious effects on endothelial cell integrity. Data from
different reports show that endothelial cells infected by
dengue virus trigger secretion of soluble factors such as
VEGF and the decrease of VEGF-R2 receptor [9,10]. We
have recently reported in vitro and in vivo showing that
soluble factors secreted from DV-infected DCs enhance
endothelial permeability and down-regulate expression of
endothelial junction proteins, Pecam-1 and VE-cadherin
in a gMMP-9-dependent manner [11]. More recently,
complementary and convergent studies, to our own pre-
vious data on dengue, have reported that Hantavirus-
infected endothelial cells enhances the permeability via
the reduction of VE-cadherin expression due to its disso-
ciation with VEGF-receptor2 (VEGF-R2) which, in turn,
become associated with VEGF [12,13]. An accurate under-
standing of Hantavirus pathogenesis is pivotal to design de
novo therapeutic or vaccine approaches that are still lack-
ing against this hemorrhagic viral infection. In this study,
we show that ANDV-infected DC are quickly activated
and rapidly progress to an intermediate maturation and
pro-inflammatory state that contributes to the increase of
soluble factors in their supernatant able to trigger the
enhancement of endothelial permeability.
Methods
Virus and cells
The primary isolate, ANDV strain CHI-7913 was propa-
gated in the epithelial Vero-E6 cell line (ATCC CRL
1586). Titrated supernatants of these cells were used to
infect, at a MOI of 1 for 2 h, human iDCs derived from
peripheral blood monocytes (PBMC), as previously
described [14]. In these experiments, UV (l:2 5 0n m ;
15 min)-irradiated ANDV was used as the negative con-
trol. Four days post-DC infection, ANDV N-protein was
detected by indirect immunofluorescence (IFA) using a
well characterized anti-ANDV N monoclonal antibody
(MAb) [15]. Total RNA was extracted using the High Pure
viral nucleic acid kit (Roche Molecular Biochemicals,
Mannheim, Germany) following the manufacture’s proto-
col and 1 μl of total RNA was amplified in a one step RT-
PCR (SuperScript III One-Step RT-PCR with Platinum
Taq, Invitrogen) using primers that recognize the nucleo-
capsid coding region (forward primer: 5’ ACA CGA ACA
ACA GCT CGT GAC ‘3 and reverse primer: 5’ AGG CTC
AAG CCC TGT TGG ATC ‘3). To assess the viral infec-
tivity, from ANDV-positive DCs, their supernatants were
used to infect Vero-E6 cells.
Phenotype profiling of ANDES-infected DC
The influence of ANDV (3 h post-viral) infection of iDCs
(as described above) was assessed through the expression
of key cell surface proteins CD80, CD83, CD86 and HLA-
DR, known to be associated with the mature DCs (mDCs)
phenotype. Pro-inflammatory profile of ANDV-infected
iDCs was assessed through the expression level of some
pro and anti-inflammatory cytokines as well as gMMP. As
infection of iDCs by other Hantaviruses induces the pro-
inflammatory cytokines expression [7]. Lipopolysaccharide
(LPS)-pulsed iDCs were used as a positive control for iDCs
maturation, while iDCs incubated with fresh culture med-
ium (mock) were used as a negative control. Supernatants
of Mock-DCs, ANDV-infected DCs, and LPS-pulsed DCs
were assessed for the production of the pro-inflammatory
cytokine, TNF-a, (ELISA kit OptEIA™ Human TNF
ELISA Kit II; Pharmingen, Franklin Lakes, NJ).
Functional assessment of ANDV-infected DC
The effect of ANDV infection on the endocytic capacity
of DCs was assessed by measuring the FITC-conjugated
Dextran up-take at 37°C [16]. In this assay, 18 h LPS-
pulsed iDCs were used as a control for cell maturation
assessment, while iDCs, incubated at 4°C, were used as
a control for the immature stage with lowest capacities
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DCs was assessed by flow cytometry using the Annexin
V assay [17] using the same previous controls.
Gelatinolytic MMP-9 secretion
Intra-cellular expression of gMMP-9 in ANDV-infected
DCs (3 h-post infection) was characterized by Western
blotting, using a mouse anti-gMMP-9 MAb (MAB13416;
Chemicon International, Temecula, CA). The gelatinolytic
activity of gMMP-9 DC supernatants (SN) was assessed by
gelatin zymography [18]. In these experiments fresh med-
ium (SN-Mock) was used as a negative control for matura-
tion, while medium containing LPS (1 μg/ml) (SN-LPS)
was used as a positive control.
Endothelial monolayer permeability assessment
The capacity to modify the vascular permeability of
ANDV-infected DC supernatants was measured in vitro,
using a monolayer of primary human umbilical vascular
endothelial cells (HUVEC) [19] Briefly, HUVEC obtained
from pooled donors were plated onto collagen-coated
transwell inserts (0.4 μm-pore, 6.5 mm-diameter Trans-
well-COL; Costar) and once in confluence cells, were
exposed for 18 h to mock-SN, virus- free SN from ANDV
infected DCs, or to TNF-a (50 nM). Monolayer endothelial
permeability was assayed with the standard cell permeabil-
ity assay according to the Chemicon ECM-640 procedure
(Millipore), by adding FITC-conjugated dextran to the
upper chamber of the transwell inserts and evaluating the
migration of FITC-conjugated Dextran to the lower cham-
ber by using a TECAN fluorometer at 490/530 nm. In this
transwell system, endothelial monolayer permeability is
directly proportional to the flux of 70-kDa dextran passing
through the HUVEC monolayer.
Statistical Methods
Data sets were compared using Kruskal & Wallis analy-
sis of variance was performed with the GraphPad Prism
4.03 software. Two-sided p-values were considered.
Results and Discussion
Primary isolate, ANDV strain CHI-7913, was shown to effi-
ciently propagated in the epithelial Vero-E6 cell line
(Figure 1A), as previously reported [20], and that their
titrated supernatants efficiently targeted and infected
human iDCs (Figure 1A). At 4 days post-infection ANDV
N-protein was detected by IFA using an anti-ANDV N
MAb. Consistent with the cell immunofluorescence data,
the presence of ANDV RNA in extensively washed infected
DCs was confirmed by an ANDV-specific RT-PCR [21]
(Figure 1B). The presence of both, viral antigens and RNA,
in DCs does not necessarily imply viral replication, as the
observations can be explained by the uptake of exogenous
viral particles by cells without productive infection. To
check for this option, infected DCs were extensively
washed and fresh medium was added. Cell supernatants
were recovered, total RNA isolated as described above and
subjected to an ANDV-specific RT-PCR. The presence of
viral RNA in DC supernatants was confirmed (Figure 1C),
suggesting shedding of de novo generated viral particles.
To assess the viral infection capacity, supernatants from
ANDV-positive DCs were used to infect Vero-E6 cells.
Five days post-infection, the presence of ANDV in Vero-E6
cells was confirmed by both IFA and RT-PCR as described
above (data not shown). Together these observations
strongly suggest that, consistent with other members of the
Hantavirus genus of the Bunyaviridae,A N D Vi sa b l et o
infect and replicate in human DCs. Consequently, we
explored the possible effects of this viral infection on both
DC phenotypes and functionalities.
The impact of DC infection by ADNV on cell viability,
maturation and endocytosis was assessed. The apoptotic
level, evaluated by flow cytometry using the Annexin V
assay [17], showed that infection of iDCs with ANDV does
not affect cell viability (Figure 2A), observations in line
with what has been reported for other hantaviruses [6,22].
In addition, ANDV infection did not induce any detectable
cytopathic effect (data not shown). DCs play a pivotal role
as antigen-presenting cells in the antiviral immune
response. It is known that infection of iDCs by diverse
viruses stimulates cell homing to inflammatory sites as
well as their maturation into antigen-presenting cells
(APC), a process essential for the initiation and modula-
tion of T cell-mediated immune responses. Hence, we
next evaluated whether ANDV infection of iDCs had a
direct effect on the expression of key cell surface proteins
CD80, CD83, CD86 and HLA-DR, known to be associated
with a mature DCs (mDCs) phenotype. Immature DCs
were infected with ANDV as described above. ANDV
infection of iDCs induced a significant increase of HLA-
DR, a marker protein that plays a pivotal role in guiding
the development and activation of CD4
+ T helper cells.
Markers CD83 and CD86 also increased, albeit to a much
l o w e re x t e n tt h a ni nL P S - p u l s e di D C sc o n d i t i o n s .A s
expected, expression of all surface markers increased in
LPS-pulsed iDCs as compared to mock-DCs (Figure 2B).
These data suggest that ANDV infection of human DCs
induced cell maturation, and that ANDV infection alters
the expression of HLA-DR on DCs. Constitutive expres-
sion of HLA-DR molecules is associated to professional
antigens presenting cells (APCs) such as DCs, this basal
expression can be enhanced in an environment enriched
with proinflammatory cytokines [7,23].
Immature DCs efficiently capture and process antigen, a
characteristic cell function that decreases with maturation
[7,8,24-27]. Therefore, we next sought to establish whether
the partial DC maturation phenotype (Figure 2B) was cor-
related with its decreased ability to capture antigens. To
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Figure 1 Detection of ANDV infection of primary human dendritic cells. (A) Vero E6 epithelial cells and human immature DCs infected with
ADNV (strain CHI-7913). ANDV-nucleocapsid (N) protein detected by IFA by incubating ANDV-infected with a mouse anti-ANDV N MAb revealed
by an FITC-conjugated anti-mouse IgG Ab (Green, right column) while the corresponding cell nuclei were stained with 4’,6-diamidino-2-
phenylindole (DAPI, blue, left column). Negative control (mock) cells were incubated with supernatant from uninfected Vero-E6 cells. (B) Total
RNA was extracted from uninfected LPS-Pulsed DCs (lane 1), ANDV-infected LPS-pulsed DCs (lane 2), uninfected iDCs (lane 3), ANDV-infected
iDCs (lane 4), ANDV-infected Vero-E6 cells (lane 5), and used as template in a RT-PCR reaction designed to specifically amplify the viral S RNA.
This assay also included a negative RT-PCR control (lane 6). MW is a molecular weight marker (1 Kb, Fermentas, Burlington, Canada). (C) DCs
generated from primary monocytes, recovered from four healthy donors, were incubated with ANDV (lanes 1, 4, 7, 10), UV-irradiated ANDV (lanes
2, 5, 8, 11) or pulsed with LPS (lanes 3, 6, 9, 12). Total RNA was extracted from cell supernatants and used as a template in a RT-PCR reaction
designed to specifically amplify the viral S RNA. MW is a molecular weight marker (100 pb, Fermentas).
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Figure 2 Impact of ANDES virus infection on iDC phenotype and functions.( A) The impact of ANDV infection on DCs viability was
detected by using the Annexin V-propidium iodide (PI) method. In these assays, DCs treated with camptothecin A (4 μM for 18 h) were used as
a positive apoptosis control. (B) DCs surface markers; CD80, CD86, CD83 and HLA-DR were analyzed in ANDV-infected iDCs by flow cytometry
four days post-ANDV infection, while LPS-pulsed DCs and uninfected iDCs (mock) were used as controls. Bar graphs represent the fold-increase
expression of these surface markers as compared their expression in mock control. Data are means of three independent experiments: *, p< 0.05;
**, p < 0.01. (C) The endocytic capacity of ANDES infected iDCs, LPS-matured DCs (mDC), uninfected iDCs incubated at 37°C (iDC 37), and
uninfected iDCs incubated at 4°C (iDC 4) was assessed using a FITC-conjugated Dextran (30 μg). Endocytosis was analyzed by flow cytometry
after 2 h of incubation. Mean fluorescence intensity values within the gate for the different endocytically active stages were plotted. Bar graphs
show the fold-increases of the mean fluorescence intensities (MFI), relative to the mock control (iDCs 37). For each experiment, 10 000 gated
cells were evaluated. Data are means of five independent experiments. *, p< 0.05; **, p < 0.01.
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Page 5 of 9this purpose, we studied the effect of ANDV infection on
the endocytic capacity of DCs by measuring the up-take of
FITC-conjugated Dextran at 37°C [16]. Results indicate
that ANDV-infected DC exhibited a reduced endocytic
capacity as compared to uninfected iDCs (Figure 2C).
However, in our conditions, infected DCs exhibited a
higher endocytic activity than the used dose of LPS to
pulse iDCs (positive control). Together, these observations
suggest that ANDV infection does indeed reduce antigen
capture by DCs, supporting a role of ANDV infection in
cell maturation.
The presence of high levels of pro-inflammatory cyto-
kines both in plasma and lungs have been reported as
pathological markers associated with HCPS in humans.
These excesses of pro-inflammatory cytokines are secreted
in patients by both hantavirus-activated macrophages and
specific T cells [28]. Particularly, the levels of the pro-
inflammatory cytokine TNF-a in HCPS patient sera are the
dramatically elevated [29,30]. Infection of iDCs by other
Hantaviruses induces the production of pro-inflammatory
c y t o k i n e sa sw e l l[ 7 ] .T h e r e f o r e ,w es o u g h tt oe v a l u a t e
whether ANDV infection induces a similar DC phenotype.
Supernatants of Mock-DCs, ANDV-infected DCs (3 h
post-viral infection), and LPS-pulsed DCs were assessed for
the production of the pro-inflammatory cytokine, TNF-a.
In agreement with what has been described for other Han-
taviruses, supernatants harvested from ANDV-infected
DCs display a significant increase in TNF-a as compared
with supernatants from uninfected iDCs (Figure 3A).
In a similar experimental setting, we also evaluated the
expression of IL-10 and TGF-b, two anti-inflammatory
cytokines [31]. Interestingly, in supernatants harvested
from ANDV-infected DCs, IL-10 levels were weakly altered
as compared with uninfected DCs, while TGF-b levels
decrease was more pronounced (Figure 3B and 3C). Thus,
our observations suggest that ANDV-infected DCs exhibit
a pro-inflammatory cytokine profile.
Upon antigen capture, DCs undergo a process of
maturation and a lymph nodes homing, where they acti-
vate the adaptive immune system. The process of DC
trafficking is complex. This phenomenon requires the
enhancement of the vascular permeability, which could
involve the expression of several components, such as
cell to cell junction proteins including VE-cadherin,
PECAM-1, occludin, claudins, as well as soluble factors,
including, IL-1b,T N F - a,V E G F ,a n dK i n i n s[ 3 2 - 3 4 ] .T h e
gelatinolytic matrix metalloproteases (gMMP)-2 and 9
are reported as one of the major actors of this crucial
phenomenon during fetal development and wound heal-
ing [35]. Interestingly, factors such as the inflammatory
cytokines IL-8, TNF-a and IL-1b as well as VEGF [36]
are in the upstream of the gMMP expression pathway in
human monocytes [37]. Additionally, even if iDC pro-
duces gMMP, DC increase the MMP-9 production along
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Figure 3 Inflammatory state of ANDV-infected iDCs. The level of
TNF-a (A) IL-10 (B), and TGF-b (C) in supernatants of uninfected
DCs (Mock), ANDV-infected iDCs (MOI = 1) (ANDV), or LPS-pulsed
DCs, was assessed by ELISA respectively at 3 h (A) and 48 h (B and
C) post-ANDV infection. In (B) and (C), bar graphs depict the fold-
increase of cytokine production relatively to mock. Data are means
of five to eight independent experiments *, p< 0.05; **, p < 0.01.
Marsac et al. Virology Journal 2011, 8:223
http://www.virologyj.com/content/8/1/223
Page 6 of 9DC maturation progression [38]. Interestingly, certain
viruses can play opposite roles in DC maturation, for
example the human Cytomegalovirus (hCMV) inhibits
cell maturation to escape the immune system (4),
whereas some others, such as HIV-1 [18], Dengue virus
[11], and West Nile virus [39], enhance DC maturation,
the secretion of active gMMP-9, as well as plasma vascu-
lar leakage. Thus, to extend our previous observation on
the fact that DCs have a proinflammatory profile that can
be compatible with the secretion of gMMP-9, we ana-
lyzed the expression and activity of gMMP-9 in cells and
its presence in DC supernatants (SN). Selection seemed
adequate as the levels of IL-10, which has been reported
to inhibit MMP-9 induction, is weakly altered by ADNV
infection (Figure 3B) and DC maturation is known to
increase the level of active MMP-9 secretion. Intra-cellu-
lar expression of gMMP-9 in ANDV-infected DCs (3 h-
post infection) was characterized by Western blotting
( F i g u r e4 A ) ,u s i n gam o u s ean anti-gMMP-9 MAb. Data
show that gMMP-9 expression is indeed elevated in
ANDV-infected DCs as compared with mock iDCs
(Figure 4A). Gelatinolytic MMP-9 is secreted as a proen-
zyme, which remains inactive unless it is activated by
the removal of the propeptide domain by proteolytic
enzymes. The gelatinolytic activity of gMMP-9 was there-
fore assessed in cell supernatants (SN) by gelatin zymo-
graphy [18]. Strikingly, ANDV-infected DC supernatants
exhibited an elevated gMMP-9 activity as compared with
SN-mock (Figure 4B). Furthermore, gMMP-9 activity
was similar to that obtained by the LPS-induction of DC
maturation (SN-LPS; Figure 4B).
ANDV belongs to the group of hemorrhagic fever
viruses known for inducing different forms of vascular
leakage in different organs. For some of these hemorrhagic
fever or encephalitic viruses the mechanism associated to
their capacity to enhance endothelial permeability in vitro
and in vivo has been reported [11,18,39]. Upon viral infec-
tion, the vascular permeability phenomenon is principally
due to viral-dependent dysfunctions of endothelial cells
junctions that can be directly induced by the action of fac-
tors from viral activated endothelial cells, such as VEGF or
indirectly induced by factors from immune viral-activated
cells, via the MAP-kinase pathway [11,18]. For these rea-
sons, we wonder if ANDV infection induced the produc-
tion of soluble factors that could indirectly enhance
endothelial permeability. To evaluate this possibility, the
capacity of ANDV infected DCs-supernatants to modify
the permeability was measured through the amounts of
FITC-conjugated dextran that passed thru a monolayer of
primary human umbilical vascular endothelial cells
(HUVEC) seeded onto transwell plates that considered as
vascular model [19]. Following the exposure of confluent
HUVEC to SN from ANDV infected DCs, or to controls,
the amounts of FITC-conjugated dextran detected in the
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Figure 4 Secretion of active gMMP-9 and endothelial
permeability enhancement are triggered by ANDV infection of
iDCs.( A) The gMMP-9 expression in ANDV-infected iDCs was
assessed by Western blotting. Uninfected iDCs (Mock), ANDV-
infected iDCs (ANDV) and LPS-treated iDCs (LPS) were collected 3 h
post-infection. Forty micrograms of total proteins from cell lysates
were separated in an 8% SDS-PAGE gel. Following an electrical
protein transfer onto a nitrocellulose membrane, an anti-gMMP-9
antibody was used to probe the presence of gMMP-9 that was
revealed using an HRP-conjugated anti-mouse IgG Ab. (B)
Supernatants from ANDV-infected DCs or Mock cells collected 3 h
post-infection. Gelatinase activity was assayed by zymography.
Gelatinolytic activity was quantified by gel densitometry using the
Image J Software. Data are presented as the fold-increase of gMMP-
9 activity in supernatants. Statistical significance (**, p < 0.01) was
determined from five independent experiments. (C) Enhancement
of the endothelial cells permeability induced by supernatant from
ANDV-infected iDCs. HUVEC confluent monolayers plated onto
collagen-coated transwell inserts were incubated with either ANDV
supernatant, mock control (uninfected DCs supernatant) or with
TNF-a (50 ng/ml) as positive control. Following 18 h at 37°C in CO2
5% after addition, within the top chamber, of 500 μg/ml FITC-
conjugated Dextran, paracellular permeability was measured by
reading in the bottom chamber containing the infiltrated FITC-
dextran at an excitation wavelength of 485 nm and an emission of
530 nm. Data represent means of five independent experiments. **,
p < 0.01.
Marsac et al. Virology Journal 2011, 8:223
http://www.virologyj.com/content/8/1/223
Page 7 of 9lower chamber of the transwell system (Figure 4C) suggest
that cell supernatant from ANDV-infected DCs contains
soluble and active factors favoring the increase of the
HUVEC monolayer permeability.
Altogether, the in vitro data presented herein show
that ANDV infects and replicates in DCs, inducing a
partial maturation and pro-inflammatory phenotype,
while increasing the expression and secretion of active
gMMP-9 as well as that supernatants from ANDV-
infected DCs were able to enhance the permeability of a
monolayer of primary human vascular endothelial cells.
Conclusion
The herein presented data and data recently published in
the literature are not only convergent but also comple-
mentary, they allow to speculate that both indirect effects
of ANDV on DCs and direct effects of pathogenic hanta-
viruses, such as ANDV, on endothelial cells generate
conjugated inflammatory consequences that result in the
increased endothelial permeability associated to this virus
infection. A better understanding of major mechanisms
involved in vascular pathogenesis observed in HCPS is
pivotal to progress in the design of therapies that today
remain unavailable for this serious life-threatening
hemorrhagic viral disease.
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